Average Co-Inventor Count = 1.85
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eli Lilly and Company (6 from 4,442 patents)
2. Elanco US Inc. (3 from 42 patents)
3. Applied Molecular Evolution (1 from 27 patents)
10 patents:
1. 12195548 - Chimeric canine anti-CD20 antibody
2. 12145972 - Neuregulin-4 compounds and methods of use
3. 11466066 - Variants of human BMP7 protein
4. 11242370 - Neuregulin-4 compounds and methods of use
5. 10941206 - Chimeric canine anti-CD20 antibody
6. 10519244 - Chimeric canine anti-CD20 antibody
7. 7927593 - TGF-beta binding antibodies
8. 7494651 - TGF-β binding antibodies
9. 7049121 - Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use
10. 6989261 - Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use